Yum! Brands Faced With Union Demands and 1 Stock Reaching 52-Week Highs

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Mylan (NASDAQ:MYL) said that its subsidiary Mylan Pharmaceuticals has won final FDA approval for its Abbreviated New Drug Application for Tolterodine Tartrate Tablets, 1 mg and 2 mg. The medication is the generic version of Pharmacia and Upjohn’s Detrol Tablets and is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Tolterodine Tartrate Tablets USP, 1 mg and 2 mg, had domestic sales of around $61.5 million for the 12 months ending September 30th, according to IMS Health. Mylan is shipping the med immediately. Shares closed up 0.37 percent on the day at $27.29, having been traded in a 52-week range of $19.31 to $27.40.

Yum! Brands (NYSE:YUM) Taco Bell is among the fast-food restaurants affected Thursday in New York, by a major effort to unionize workers in the sector. Forty full-time organizers have been recruited by community groups and a labor union for the campaign in recent months, according to The New York Times. Restaurants impacted include McDonald’s, Wendy’s, and others. Yum! shares closed up 0.78 percent on the day at $74.47, and have been traded in a 52-week range of $55.88 to $74.44.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business